Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Kunkel Lori Anne
Over the trailing 90 days, Kunkel Lori Anne (Other at Enliven Therapeutics, Inc.) sold $850K of stock in ELVN, per 5 SEC Form 4 transactions.
- Role
- Other
- Companies
- ELVN
- Window
- Trailing 90 days · 5 transactions · CIK 1536368
- Net activity
- −$850K ($0 bought · $850K sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| ELVN | Enliven Therapeutics, Inc. | 5 | — | $850K | −$850K |
Transactions (5)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-06 | ELVN | Sell | 4.1K | $205K | Open market or private sale |
| 2026-07-06 | ELVN | Sell | 5.9K | $299K | Open market or private sale |
| 2026-06-05 | ELVN | Sell | 7.8K | $267K | Open market or private sale |
| 2026-06-05 | ELVN | Sell | 354 | $13K | Open market or private sale |
| 2026-06-05 | ELVN | Sell | 1.9K | $66K | Open market or private sale |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Kunkel's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.